MediPharm Labs to Support Major Clinical Study at Mount Sinai to Develop Opioid Addiction Treatment MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX:... read more → May 22, 2019 Ryan T.